| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MAGELLAN MIDSTREAM PRTNRS LP | 42,311 | 2,874,000 | 7.89% | ||
| 2 | ENERGY TRANSFER PRTNRS L P | 55,000 | 1,855,000 | 5.09% | Call | |
| 3 | BUCKEYE PARTNERS L P UNIT LTD PARTN | 24,889 | 1,642,000 | 4.51% | ||
| 4 | WILLIAMS COS INC DEL | 63,805 | 1,640,000 | 4.50% | ||
| 5 | ENTERPRISE PRODS PARTNERS L | 55,762 | 1,426,000 | 3.91% | ||
| 6 | WILLIAMS COS INC DEL | 45,000 | 1,157,000 | 3.18% | Call | |
| 7 | ENTERPRISE PRODS PARTNERS L | 45,000 | 1,151,000 | 3.16% | Call | |
| 8 | OMEROS CORP | 44,237 | 696,000 | 1.91% | ||
| 9 | KERYX BIOPHARMACEUTICALS INCORPORATED | 136,472 | 689,000 | 1.89% | ||
| 10 | WESTERN GAS PARTNERS LP | 14,300 | 680,000 | 1.87% | ||
| 11 | AEGERION PHARMACEUTICALS INC | 64,959 | 656,000 | 1.80% | ||
| 12 | SEATTLE GENETICS INC | 14,541 | 653,000 | 1.79% | ||
| 13 | IONIS PHARMACEUTICALS INC | 10,447 | 647,000 | 1.78% | ||
| 14 | NEKTAR THERAPEUTICS COM | 38,260 | 645,000 | 1.77% | ||
| 15 | PROGENICS PHARMACEUTICALS IN | 103,807 | 636,000 | 1.75% | ||
| 16 | VANDA PHARMACEUTICALS INC COM | 67,021 | 624,000 | 1.71% | ||
| 17 | ARENA PHARMACEUTICALS INC | 323,107 | 614,000 | 1.69% | ||
| 18 | ALEXION PHARMACEUTIC | 3,167 | 604,000 | 1.66% | ||
| 19 | GENESIS ENERGY LP COM UNITS NPV | 16,278 | 598,000 | 1.64% | ||
| 20 | AMGEN INC | 3,644 | 592,000 | 1.62% | ||
| 21 | PHILLIPS 66 PARTNERS LP | 9,581 | 588,000 | 1.61% | ||
| 22 | GILEAD SCIENCES INC | 5,810 | 588,000 | 1.61% | ||
| 23 | CELGENE CORP | 4,884 | 585,000 | 1.61% | ||
| 24 | Anacor Pharmaceuticals Inc | 5,147 | 581,000 | 1.59% | ||
| 25 | MEDICINES CO | 15,331 | 572,000 | 1.57% | ||
| 26 | PLAINS ALL AMERN PIPELINE L | 24,737 | 571,000 | 1.57% | ||
| 27 | RETROPHIN INC COM | 28,634 | 552,000 | 1.52% | ||
| 28 | SPECTRA ENERGY CORP | 17,608 | 422,000 | 1.16% | ||
| 29 | CRESTWOOD EQUITY PARTNERS LP | 19,580 | 407,000 | 1.12% | ||
| 30 | PLAINS ALL AMERN PIPELINE L | 15,000 | 347,000 | 0.95% | Call | |
| 31 | ADVAXIS INC COM NEW | 33,234 | 334,000 | 0.92% | ||
| 32 | Atara Biotherapeutics Inc | 12,137 | 321,000 | 0.88% | ||
| 33 | BELLICUM PHARMACEUTICALS INC COM | 15,086 | 306,000 | 0.84% | ||
| 34 | IGNYTA INC COM | 22,638 | 303,000 | 0.83% | ||
| 35 | PARATEK PHARMACEUTICALS INC | 15,819 | 300,000 | 0.82% | ||
| 36 | OPHTHOTECH CORP COM | 3,735 | 293,000 | 0.80% | ||
| 37 | CARA THERAPEUTICS INC | 17,299 | 292,000 | 0.80% | ||
| 38 | Arrowhead Pharma Inc | 47,549 | 292,000 | 0.80% | ||
| 39 | GERON CORP | 59,436 | 288,000 | 0.79% | ||
| 40 | PORTOLA PHARMACEUTICALS INC | 5,561 | 286,000 | 0.79% | ||
| 41 | INSMED INC COM PAR .01 | 15,716 | 285,000 | 0.78% | ||
| 42 | IMMUNOMEDICS INC | 92,480 | 284,000 | 0.78% | ||
| 43 | SEMPRA ENERGY | 3,017 | 284,000 | 0.78% | ||
| 44 | SANGAMO BIOSCIENCES INCORPORATED | 30,847 | 282,000 | 0.77% | ||
| 45 | CLOVIS ONCOLOGY INC | 7,999 | 280,000 | 0.77% | ||
| 46 | ACADIA PHARMACEUTICALS INC COM | 7,814 | 279,000 | 0.77% | ||
| 47 | RELYPSA INC | 9,802 | 278,000 | 0.76% | ||
| 48 | SAREPTA THERAPEUTICS INC | 7,203 | 278,000 | 0.76% | ||
| 49 | LA JOLLA PHARMACEUTICAL CO | 10,250 | 277,000 | 0.76% | ||
| 50 | MACROGENICS INC | 8,911 | 276,000 | 0.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-014887, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
